Loading…

Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome

To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS). Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 2006-06, Vol.126 (2), p.201-205
Main Authors: Kurabayashi, Takumi, Suzuki, Mina, Fujita, Kazuyuki, Murakawa, Haruo, Hasegawa, Isao, Tanaka, Kenichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953
cites cdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953
container_end_page 205
container_issue 2
container_start_page 201
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 126
creator Kurabayashi, Takumi
Suzuki, Mina
Fujita, Kazuyuki
Murakawa, Haruo
Hasegawa, Isao
Tanaka, Kenichi
description To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS). Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed. For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120 min, the area under the curve (AUC) and blood insulin levels at 120 min in the non-responder group ( n = 25) were significantly higher than those in the responder group ( n = 34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120 mg/dl for the blood glucose level at 120 min and 9000 for the blood glucose × insulin level at 120 min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived ( n = 9) and non-conceived groups ( n = 21). The levels of blood glucose and blood glucose × insulin at 120 min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.
doi_str_mv 10.1016/j.ejogrb.2005.11.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68017600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030121150500610X</els_id><sourcerecordid>68017600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</originalsourceid><addsrcrecordid>eNp9kE1P4zAYhK0VKyhd_sEK-QK3ZP3Gie1ckBDiS0KCw-51Ldd5U1wlcbDTov57XFqJG76MLD0zHg8hv4HlwED8WeW48suwyAvGqhwgT_KDzEDJIpOiKo_IjHEGWQFQnZDTGFcsHc7rY3ICgnMpCzUj_1-CXw4-Ts7S1tjJh0hbH6jfrDuTblsaMI5-iEjf3fRKbed7N77igNS6KZgJqRvo6Lut3X6G-I1JprgdmuB7_EV-tqaLeHbQOfl3d_v35iF7er5_vLl-yiyv2ZQJlcqrBQBTYBiUrKxrRC5bqzg3tZTMomlQSVW0diFEiUwUFahaCqWauuJzcrnPHYN_W2OcdO-ixa4zA_p11OkBkCJ9f07KPWiDjzFgq8fg-lRZA9O7XfVK73fVu101gE6SbOeH_PWix-bLdBgyARcHwERrujaYwbr4xUnFVcV54q72HKY1Ng6DjtbhYLFxAe2kG---b_IBu_KY8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68017600</pqid></control><display><type>article</type><title>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</title><source>ScienceDirect Journals</source><creator>Kurabayashi, Takumi ; Suzuki, Mina ; Fujita, Kazuyuki ; Murakawa, Haruo ; Hasegawa, Isao ; Tanaka, Kenichi</creator><creatorcontrib>Kurabayashi, Takumi ; Suzuki, Mina ; Fujita, Kazuyuki ; Murakawa, Haruo ; Hasegawa, Isao ; Tanaka, Kenichi</creatorcontrib><description>To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS). Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed. For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120 min, the area under the curve (AUC) and blood insulin levels at 120 min in the non-responder group ( n = 25) were significantly higher than those in the responder group ( n = 34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120 mg/dl for the blood glucose level at 120 min and 9000 for the blood glucose × insulin level at 120 min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived ( n = 9) and non-conceived groups ( n = 21). The levels of blood glucose and blood glucose × insulin at 120 min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2005.11.005</identifier><identifier>PMID: 16337728</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>75-g OGTT ; Administration, Oral ; Adult ; Anovulation ; Area Under Curve ; Biological and medical sciences ; Blood Glucose ; Clomiphene ; Clomiphene - administration &amp; dosage ; Clomiphene - pharmacology ; Female ; Female genital diseases ; Fertility Agents, Female - administration &amp; dosage ; Fertility Agents, Female - pharmacology ; Gynecology. Andrology. Obstetrics ; Humans ; Insulin - blood ; Insulin resistance ; Medical sciences ; Non tumoral diseases ; Ovulation - drug effects ; Ovulation Induction ; Polycystic ovary syndrome ; Polycystic Ovary Syndrome - blood ; Predictive Value of Tests ; Prospective Studies ; ROC Curve</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2006-06, Vol.126 (2), p.201-205</ispartof><rights>2005 Elsevier Ireland Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</citedby><cites>FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17838533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16337728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kurabayashi, Takumi</creatorcontrib><creatorcontrib>Suzuki, Mina</creatorcontrib><creatorcontrib>Fujita, Kazuyuki</creatorcontrib><creatorcontrib>Murakawa, Haruo</creatorcontrib><creatorcontrib>Hasegawa, Isao</creatorcontrib><creatorcontrib>Tanaka, Kenichi</creatorcontrib><title>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS). Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed. For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120 min, the area under the curve (AUC) and blood insulin levels at 120 min in the non-responder group ( n = 25) were significantly higher than those in the responder group ( n = 34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120 mg/dl for the blood glucose level at 120 min and 9000 for the blood glucose × insulin level at 120 min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived ( n = 9) and non-conceived groups ( n = 21). The levels of blood glucose and blood glucose × insulin at 120 min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.</description><subject>75-g OGTT</subject><subject>Administration, Oral</subject><subject>Adult</subject><subject>Anovulation</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose</subject><subject>Clomiphene</subject><subject>Clomiphene - administration &amp; dosage</subject><subject>Clomiphene - pharmacology</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Fertility Agents, Female - administration &amp; dosage</subject><subject>Fertility Agents, Female - pharmacology</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Insulin - blood</subject><subject>Insulin resistance</subject><subject>Medical sciences</subject><subject>Non tumoral diseases</subject><subject>Ovulation - drug effects</subject><subject>Ovulation Induction</subject><subject>Polycystic ovary syndrome</subject><subject>Polycystic Ovary Syndrome - blood</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>ROC Curve</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P4zAYhK0VKyhd_sEK-QK3ZP3Gie1ckBDiS0KCw-51Ldd5U1wlcbDTov57XFqJG76MLD0zHg8hv4HlwED8WeW48suwyAvGqhwgT_KDzEDJIpOiKo_IjHEGWQFQnZDTGFcsHc7rY3ICgnMpCzUj_1-CXw4-Ts7S1tjJh0hbH6jfrDuTblsaMI5-iEjf3fRKbed7N77igNS6KZgJqRvo6Lut3X6G-I1JprgdmuB7_EV-tqaLeHbQOfl3d_v35iF7er5_vLl-yiyv2ZQJlcqrBQBTYBiUrKxrRC5bqzg3tZTMomlQSVW0diFEiUwUFahaCqWauuJzcrnPHYN_W2OcdO-ixa4zA_p11OkBkCJ9f07KPWiDjzFgq8fg-lRZA9O7XfVK73fVu101gE6SbOeH_PWix-bLdBgyARcHwERrujaYwbr4xUnFVcV54q72HKY1Ng6DjtbhYLFxAe2kG---b_IBu_KY8A</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Kurabayashi, Takumi</creator><creator>Suzuki, Mina</creator><creator>Fujita, Kazuyuki</creator><creator>Murakawa, Haruo</creator><creator>Hasegawa, Isao</creator><creator>Tanaka, Kenichi</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060601</creationdate><title>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</title><author>Kurabayashi, Takumi ; Suzuki, Mina ; Fujita, Kazuyuki ; Murakawa, Haruo ; Hasegawa, Isao ; Tanaka, Kenichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>75-g OGTT</topic><topic>Administration, Oral</topic><topic>Adult</topic><topic>Anovulation</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose</topic><topic>Clomiphene</topic><topic>Clomiphene - administration &amp; dosage</topic><topic>Clomiphene - pharmacology</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Fertility Agents, Female - administration &amp; dosage</topic><topic>Fertility Agents, Female - pharmacology</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Insulin - blood</topic><topic>Insulin resistance</topic><topic>Medical sciences</topic><topic>Non tumoral diseases</topic><topic>Ovulation - drug effects</topic><topic>Ovulation Induction</topic><topic>Polycystic ovary syndrome</topic><topic>Polycystic Ovary Syndrome - blood</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>ROC Curve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurabayashi, Takumi</creatorcontrib><creatorcontrib>Suzuki, Mina</creatorcontrib><creatorcontrib>Fujita, Kazuyuki</creatorcontrib><creatorcontrib>Murakawa, Haruo</creatorcontrib><creatorcontrib>Hasegawa, Isao</creatorcontrib><creatorcontrib>Tanaka, Kenichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurabayashi, Takumi</au><au>Suzuki, Mina</au><au>Fujita, Kazuyuki</au><au>Murakawa, Haruo</au><au>Hasegawa, Isao</au><au>Tanaka, Kenichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>126</volume><issue>2</issue><spage>201</spage><epage>205</epage><pages>201-205</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS). Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed. For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120 min, the area under the curve (AUC) and blood insulin levels at 120 min in the non-responder group ( n = 25) were significantly higher than those in the responder group ( n = 34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120 mg/dl for the blood glucose level at 120 min and 9000 for the blood glucose × insulin level at 120 min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived ( n = 9) and non-conceived groups ( n = 21). The levels of blood glucose and blood glucose × insulin at 120 min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>16337728</pmid><doi>10.1016/j.ejogrb.2005.11.005</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2006-06, Vol.126 (2), p.201-205
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_68017600
source ScienceDirect Journals
subjects 75-g OGTT
Administration, Oral
Adult
Anovulation
Area Under Curve
Biological and medical sciences
Blood Glucose
Clomiphene
Clomiphene - administration & dosage
Clomiphene - pharmacology
Female
Female genital diseases
Fertility Agents, Female - administration & dosage
Fertility Agents, Female - pharmacology
Gynecology. Andrology. Obstetrics
Humans
Insulin - blood
Insulin resistance
Medical sciences
Non tumoral diseases
Ovulation - drug effects
Ovulation Induction
Polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Predictive Value of Tests
Prospective Studies
ROC Curve
title Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A03%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20factors%20for%20ovulatory%20response%20with%20clomiphene%20citrate%20in%20polycystic%20ovary%20syndrome&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Kurabayashi,%20Takumi&rft.date=2006-06-01&rft.volume=126&rft.issue=2&rft.spage=201&rft.epage=205&rft.pages=201-205&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/j.ejogrb.2005.11.005&rft_dat=%3Cproquest_cross%3E68017600%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68017600&rft_id=info:pmid/16337728&rfr_iscdi=true